Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peer Christiansen

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Epidemiology (Cambridge, Mass.)|March 24, 2016
Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer RecurrenceDeirdre P Cronin-Fenton, Uffe Heide-Jørgensen, Thomas P Ahern, et al.
Journal of Surgical Oncology|March 19, 2016
Importance of margin width in breast-conserving treatment of early breast cancerAnne Bodilsen, Karsten Bjerre, Birgitte V Offersen, et al.
Breast (Edinburgh, Scotland)|October 12, 2007
Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative GroupAnders Husted Madsen, Karen Haugaard, Jan Soerensen, et al.
European Radiology|May 19, 2021
Comparison of contrast-enhanced CT, dual-layer detector spectral CT, and whole-body MRI in suspected metastatic breast cancer: a prospective diagnostic accuracy studyThomas Winther Buus, Finn Rasmussen, Hanne Marie Nellemann, et al.
Acta Oncologica (Stockholm, Sweden)|October 2, 2007
Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?Stefano Christian Londero, Christian Godballe, Annelise Krogdahl, et al.
Acta Oncologica (Stockholm, Sweden)|May 10, 2008
Breast conserving treatment in Denmark, 1989-1998. A nationwide population-based study of the Danish Breast Cancer Co-operative GroupMarianne Ewertz, Mette Moe Kempel, Maria Düring, et al.
Breast Cancer Research : BCR|July 11, 2025
The association between body mass index and neoadjuvant chemotherapy response in patients with breast cancerJonas Busk Holm, Stine Blaabjerg Skovbjerg, Hanne Melgaard Nielsen, et al.
Neuroendocrinology|February 2, 2006
Secretagogin is a novel marker for neuroendocrine differentiationKarin Birkenkamp-Demtröder, Ludwig Wagner, Flemming Brandt Sørensen, et al.
Breast Cancer Research and Treatment|June 18, 2010
Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancerKirsten Vang Nielsen, Bent Ejlertsen, Sven Müller, et al.
Scandinavian Journal of Work, Environment & Health|November 15, 2016
Short-term effects of night shift work on breast cancer risk: a cohort study of payroll dataHelene Tilma Vistisen, Anne Helene Garde, Morten Frydenberg, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Epidemiology (Cambridge, Mass.)|March 24, 2016
Low-dose Aspirin, Nonsteroidal Anti-inflammatory Drugs, Selective COX-2 Inhibitors and Breast Cancer RecurrenceDeirdre P Cronin-Fenton, Uffe Heide-Jørgensen, Thomas P Ahern, et al.
Journal of Surgical Oncology|March 19, 2016
Importance of margin width in breast-conserving treatment of early breast cancerAnne Bodilsen, Karsten Bjerre, Birgitte V Offersen, et al.
Breast (Edinburgh, Scotland)|October 12, 2007
Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative GroupAnders Husted Madsen, Karen Haugaard, Jan Soerensen, et al.
European Radiology|May 19, 2021
Comparison of contrast-enhanced CT, dual-layer detector spectral CT, and whole-body MRI in suspected metastatic breast cancer: a prospective diagnostic accuracy studyThomas Winther Buus, Finn Rasmussen, Hanne Marie Nellemann, et al.
Acta Oncologica (Stockholm, Sweden)|October 2, 2007
Papillary microcarcinoma of the thyroid gland: is the immunohistochemical expression of cyclin D1 or galectin-3 in primary tumour an indicator of metastatic disease?Stefano Christian Londero, Christian Godballe, Annelise Krogdahl, et al.
Acta Oncologica (Stockholm, Sweden)|May 10, 2008
Breast conserving treatment in Denmark, 1989-1998. A nationwide population-based study of the Danish Breast Cancer Co-operative GroupMarianne Ewertz, Mette Moe Kempel, Maria Düring, et al.
Breast Cancer Research : BCR|July 11, 2025
The association between body mass index and neoadjuvant chemotherapy response in patients with breast cancerJonas Busk Holm, Stine Blaabjerg Skovbjerg, Hanne Melgaard Nielsen, et al.
Neuroendocrinology|February 2, 2006
Secretagogin is a novel marker for neuroendocrine differentiationKarin Birkenkamp-Demtröder, Ludwig Wagner, Flemming Brandt Sørensen, et al.
Breast Cancer Research and Treatment|June 18, 2010
Amplification of ESR1 may predict resistance to adjuvant tamoxifen in postmenopausal patients with hormone receptor positive breast cancerKirsten Vang Nielsen, Bent Ejlertsen, Sven Müller, et al.
Scandinavian Journal of Work, Environment & Health|November 15, 2016
Short-term effects of night shift work on breast cancer risk: a cohort study of payroll dataHelene Tilma Vistisen, Anne Helene Garde, Morten Frydenberg, et al.
Pageof 13